Inhibiting the type 2 inflammatory pathway with dupilumab is associated with an increase in interleukin-4 and interleukin-18 production.
Int Forum Allergy Rhinol
; 12(10): 1313-1316, 2022 10.
Article
in En
| MEDLINE
| ID: mdl-35394682
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Sinusitis
/
Rhinitis
/
Nasal Polyps
Type of study:
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Int Forum Allergy Rhinol
Year:
2022
Document type:
Article
Country of publication:
United States